KEGG   PATHWAY: mlk04650
Entry
mlk04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Mustela lutreola (European mink)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
mlk04650  Natural killer cell mediated cytotoxicity
mlk04650

Other DBs
GO: 0042267
Organism
Mustela lutreola (European mink) [GN:mlk]
Gene
131807426  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
131807620  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
131808568  [KO:K07360] [EC:2.7.10.2]
131809015  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
131809629  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
131810028  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
131810162  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
131810307  NRAS; GTPase NRas isoform X1 [KO:K07828]
131810524  [KO:K07828]
131810821  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
131811048  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
131811758  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
131812130  [KO:K05414]
131812466  [KO:K05414]
131812476  SHC3; SHC-transforming protein 3 [KO:K17448]
131812504  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
131812513  [KO:K05414]
131812526  [KO:K05414]
131812530  [KO:K05414]
131812531  [KO:K05414]
131812533  [KO:K05414]
131812535  [KO:K05414]
131812554  [KO:K05414]
131812572  [KO:K05414]
131812581  [KO:K05414]
131812595  [KO:K05414]
131812613  [KO:K05414]
131812617  [KO:K05414]
131812618  [KO:K05414]
131812658  [KO:K05414]
131812659  [KO:K05414]
131812695  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
131812838  [KO:K05414]
131813182  IFNB1; interferon beta [KO:K05415]
131813239  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
131814327  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
131814353  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
131814729  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
131814778  CD48; CD48 antigen isoform X1 [KO:K06479]
131814804  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
131814889  [KO:K06463]
131814928  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
131815231  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
131815676  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
131815964  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
131816784  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
131816825  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
131817431  [KO:K04722]
131818057  TYROBP; TYRO protein tyrosine kinase-binding protein isoform X1 [KO:K07992]
131818058  HCST; hematopoietic cell signal transducer [KO:K07988]
131818337  HRAS; GTPase HRas isoform X1 [KO:K02833]
131818792  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
131818861  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
131818889  [KO:K06741]
131819303  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
131819447  LAT; LOW QUALITY PROTEIN: linker for activation of T-cells family member 1 [KO:K07362]
131819600  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
131819826  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
131820131  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
131820467  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
131821130  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
131821685  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
131823143  SHC2; SHC-transforming protein 2 [KO:K17447]
131823312  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
131823393  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
131823508  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
131823754  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
131824239  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
131824589  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
131824847  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
131824863  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
131825324  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
131825325  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
131825470  ITGB2; integrin beta-2 [KO:K06464]
131826902  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
131828824  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
131828867  PRF1; perforin-1 isoform X1 [KO:K07818]
131829849  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
131829901  PPP3CA; protein phosphatase 3 catalytic subunit alpha isoform X1 [KO:K04348] [EC:3.1.3.16]
131830067  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
131831899  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
131832013  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
131832309  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
131833089  [KO:K07986]
131833090  [KO:K07986]
131833269  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
131833465  [KO:K07986]
131833494  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
131833683  [KO:K07986]
131833755  IFNGR1; interferon gamma receptor 1 [KO:K05132]
131833951  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
131834170  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
131834372  TNF; tumor necrosis factor isoform X1 [KO:K03156]
131834374  NCR3; natural cytotoxicity triggering receptor 3 isoform X1 [KO:K06743]
131834535  [KO:K07986]
131835957  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
131836254  SHC4; SHC-transforming protein 4 [KO:K17449]
131836421  [KO:K01353] [EC:3.4.21.79]
131836536  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
131838342  BID; BH3-interacting domain death agonist [KO:K04726]
131838464  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
131838926  KRAS; GTPase KRas isoform X1 [KO:K07827]
131839043  [KO:K06541]
131839044  [KO:K06541]
131839045  [KO:K06541]
131839046  [KO:K06541]
131839047  [KO:K06541]
131839048  [KO:K06541]
131839049  [KO:K06541]
131839050  KLRK1; NKG2-D type II integral membrane protein isoform X1 [KO:K06728]
131839053  KLRD1; natural killer cells antigen CD94 isoform X1 [KO:K06516]
131839127  IFNG; interferon gamma [KO:K04687]
131839444  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
131839810  [KO:K06541]
131840354  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
131840500  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
mlk04010  MAPK signaling pathway
mlk04020  Calcium signaling pathway
mlk04060  Cytokine-cytokine receptor interaction
mlk04210  Apoptosis
mlk04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system